100 related articles for article (PubMed ID: 9127128)
21. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
[TBL] [Abstract][Full Text] [Related]
22. Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man.
Coiro V; Passeri M; Volpi R; Marchesi M; Bertoni P; Fagnoni F; Schianchi L; Bianconi L; Marcato A; Chiodera P
Horm Res; 1989; 32(4):119-23. PubMed ID: 2560454
[TBL] [Abstract][Full Text] [Related]
23. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
24. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
25. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
26. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
[TBL] [Abstract][Full Text] [Related]
27. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Moggi L; Fioretti P
J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
[TBL] [Abstract][Full Text] [Related]
28. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
29. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
Xiao E; Xia-Zhang L; Thornell D; Shalts E; Ferin M
Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
[TBL] [Abstract][Full Text] [Related]
30. Age- and sex-specific changes in naloxone-induced luteinizing hormone secretion and Fos expression in gonadotropin-releasing hormone neurons of gonadectomized rats.
Funabashi T; Furuta M; Fukushima A; Kimura F
Neurosci Lett; 2010 Mar; 471(3):157-61. PubMed ID: 20097261
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam.
Van Vugt DA; Washburn DL; Farley AE; Reid RL
Neuroendocrinology; 1997 May; 65(5):344-52. PubMed ID: 9158066
[TBL] [Abstract][Full Text] [Related]
32. Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion.
Limonta P; Dondi D; Maggi R; Martini L; Piva F
Endocrinology; 1989 Feb; 124(2):681-6. PubMed ID: 2912695
[TBL] [Abstract][Full Text] [Related]
33. Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy.
Petraglia F; Larizza D; Maghnie M; Facchinetti F; Volpe A; Bernasconi S; Genazzani AR; Severi F
J Clin Endocrinol Metab; 1988 May; 66(5):1024-8. PubMed ID: 3129445
[TBL] [Abstract][Full Text] [Related]
34. The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Verhelst J; Beckers A; Abs R
Fertil Steril; 1995 Nov; 64(5):969-71. PubMed ID: 7589643
[TBL] [Abstract][Full Text] [Related]
35. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
36. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
[TBL] [Abstract][Full Text] [Related]
37. The effects of opiate antagonism on gonadotropin secretion in children and in women with hypothalamic amenorrhea.
Sauder SE; Case GD; Hopwood NJ; Kelch RP; Marshall JC
Pediatr Res; 1984 Apr; 18(4):322-8. PubMed ID: 6326037
[TBL] [Abstract][Full Text] [Related]
38. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
Perkins RB; Hall JE; Martin KA
J Clin Endocrinol Metab; 1999 Jun; 84(6):1905-11. PubMed ID: 10372685
[TBL] [Abstract][Full Text] [Related]
40. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women.
Hall JE; Lavoie HB; Marsh EE; Martin KA
J Clin Endocrinol Metab; 2000 May; 85(5):1794-800. PubMed ID: 10843154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
